These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Inhibitors of coagulation-fibrinolysis system and platelet function in patients with vertigo. Noda Y, Nakamura M, Sasaki M, Kosugi T. Auris Nasus Larynx; 1986; 13 Suppl 1():S75-9. PubMed ID: 2429647 [Abstract] [Full Text] [Related]
25. Activation of both coagulation and fibrinolysis in childhood hemolytic uremic syndrome. Van Geet C, Proesmans W, Arnout J, Vermylen J, Declerck PJ. Kidney Int; 1998 Oct; 54(4):1324-30. PubMed ID: 9767551 [Abstract] [Full Text] [Related]
29. Studies of fibrinolytic activity of uremic and longterm hemodialytic patients with special reference to fibrinolytic inhibitor. Homma T, Ichikawa T. Biochem Exp Biol; 1979 Oct; 15(3):229-36. PubMed ID: 122165 [Abstract] [Full Text] [Related]
32. [Molecular markers of hemostatic-mechanisms--plasmin-alpha 2 plasmin inhibitor complex]. Kawai Y, Watanabe K. Rinsho Byori; 1989 Mar; 37(3):248-55. PubMed ID: 2526263 [No Abstract] [Full Text] [Related]
33. Oxidative stress effects fibrinolytic system in dialysis uraemic patients. Pawlak K, Pawlak D, Mysliwiec M. Thromb Res; 2006 Mar; 117(5):517-22. PubMed ID: 15964061 [Abstract] [Full Text] [Related]
34. Plasma alpha 2-plasmin inhibitor-plasmin complex and FDP-D-Dimer in fulminant hepatic failure. Tomiya T, Hayashi S, Ogata I, Fujiwara K. Thromb Res; 1989 Feb 01; 53(3):253-60. PubMed ID: 2524118 [Abstract] [Full Text] [Related]
35. Dysfunctional coagulation and fibrinolysis systems due to adenomyosis is a possible cause of thrombosis and menorrhagia. Yamanaka A, Kimura F, Yoshida T, Kita N, Takahashi K, Kushima R, Murakmai T. Eur J Obstet Gynecol Reprod Biol; 2016 Sep 01; 204():99-103. PubMed ID: 27543913 [Abstract] [Full Text] [Related]
36. [Clinical relevance of determination of plasma ATIII and alpha 2 PI activities in patients with DIC--application of the molecular markers for the analysis of pathophysiology of DIC]. Okajima K. Rinsho Byori; 1994 Jan 01; 42(1):45-55. PubMed ID: 8107283 [Abstract] [Full Text] [Related]
37. [Analysis of alpha 2-plasmin inhibitor]. Mimuro J, Aoki N. Rinsho Byori; 1985 Feb 01; Spec No 61():97-105. PubMed ID: 2860263 [No Abstract] [Full Text] [Related]
38. [On coagulation and fibrinolysis in renal diseases, with special reference to FDP subfragment and urinary plasmin body]. Nakamichi S. Nihon Jinzo Gakkai Shi; 1984 Apr 01; 26(4):353-66. PubMed ID: 6236317 [No Abstract] [Full Text] [Related]
39. [Relation between blood coagulability and prognosis in patients with ovarian cancer]. Sawaguchi K, Narumiya H, Yabushita H, Noguchi M, Nakanishi M. Nihon Sanka Fujinka Gakkai Zasshi; 1990 Apr 01; 42(4):313-9. PubMed ID: 2358716 [Abstract] [Full Text] [Related]
40. [Study on coagulation fibrinolytic systems in predialysis patients with chronic renal failure--comparison between patients with chronic glomerulonephritis and patients with diabetic nephropathy]. Nagake Y, Makino H, Yorioka N, Nomura S, Osawa G, Yamakido M, Kawasaki H, Kato Y, Matsuzaki M, Shikata K, Uemasu J, Somiya H, Fujii Z, Hayashida S, Nasu T, Oyabu Y, Nitta Y, Kawanishi H, Usui K, Fujiwara K, Takasugi N, Kanehara K, Hamaguchi N, Kumagai I, Ota Z. Nihon Jinzo Gakkai Shi; 1997 Jul 01; 39(5):474-82. PubMed ID: 9283213 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]